Dosage Information for Arexvy: Forms, Strengths, Usage Guidelines, and Additional Details
Arexvy, a brand-name drug, has been approved by the Food and Drug Administration (FDA) for the prevention of lower respiratory tract disease in adults aged 60 and above, caused by the Respiratory Syncytial Virus (RSV).
This vaccine is administered as a one-time intramuscular injection, similar to Abrysvo. You will likely go to your doctor's office or a pharmacy to receive your Arexvy injection. The typical dosage is a single 0.5 mL dose.
Arexvy is specifically indicated for active immunization to prevent serious lower respiratory tract infections caused by RSV in adults aged 60 years and older. It is important to note that no routine repeat doses have been established as of current guidance.
The administration of Arexvy aligns with current practice guidelines and product labeling for vaccinated older adults. It is typically administered before the RSV season but can be given at any time during the year.
Arexvy is a biologic and belongs to a drug class called recombinant vaccines. It comes as two vials - one liquid and one powder - that are mixed to form a liquid solution for intramuscular injection.
If you have questions about how to use Arexvy, you can talk with your doctor or pharmacist. Always follow the dosage that your doctor prescribes for you.
It is crucial to remember that Arexvy is not available in a biosimilar version. For more detailed information, you can refer to additional articles such as "More about Arexvy", "Side effects", "Interactions", etc., available on the manufacturer's website.
Stay informed and protect yourself from RSV. Consult with your healthcare professional to determine if Arexvy is the right choice for you.
